Delays in Core Laboratory Testing, Monday, November 23, 2015
Today, November 23, 2015, instrumentation in the core clinical laboratory will be undergoing required maintenance from approximately 09:30 – 12:30. This will delay the resulting of the following assays in that time window:
- Alpha-1 antitrypsin [LAB927]
- Angiotensin converting enzyme [LAB563]
- Amikacin drug level [Epic LAB555]
- Carbamazepine drug level [Epic LAB22]
- Ceruloplasmin [LAB582]
- Drug of abuse – urine screens [Epic LAB500 and LAB1032]
- Ethylene glycol, plasma (by immunoassay) [LAB7453]
- Everolimus drug level [LAB7456]
- Haptoglobin [LAB89]
- Homocysteine [LAB93]
- IgA [LAB73]
- IgG [LAB71]
- IgM [LAB72]
- Keppra (levetiracetam) drug level [LAB477]
- Lamotrigine drug level (LAB475]
- Lidocaine drug level [LAB641]
- Methotrexate drug level [Epic LAB481]
- Nicotine metabolite, rapid screen [LAB8071]
- Pentobarbital drug level [LAB656]
- Phenobarbital drug level [Epic LAB30]
- Phenytoin free drug level [Epic LAB32]
- Rheumatoid factor [LAB206]
- Theophylline drug level [LAB35]
- Tobramycin drug level [Epic LAB36]
- Valproic acid drug level [Epic LAB25]
Questions should be directed to Matthew Krasowski, MD, PhD, medical director of the Clinical Chemistry Laboratory (384-9380, matthew-krasowski@uiowa.edu).